MENU
IMNM
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Immunome (IMNM) Ownership - Who owns Immunome?
Profile
Industry
N/A
Address
18702 N. Creek Parkway
Phone
+1 610 321-3700
Employees
55
Web
https://www.immunome.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
750.25M
P/E Ratio
N/A
Total Cash
240.13M
Projected Growth
N/A
Total Debt
2.72M
Revenue
10.13M
Risk (Beta)
2.95
Dividend Yield
N/A
Total Cash/Share
3.85
Total Debt/Equity
N/A
Revenue/Share
0.19 USD as % of share price
Fundamentals
IMNM
Capitalization
750M
P/E Ratio
N/A
Risk (Beta)
2.95
Dividend Yield
N/A
Total Cash
240M
Total Cash/Share
3.85
Total Debt
2.72M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.19%
Revenue
10.1M
ROE
N/A
Book Value
215M
P/B Ratio
3.61
Cash Flow
N/A
Earnings
-7.94
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
6K
Current Ratio
6.17
Current Revenue Per Employee
27714.28
Dividends Per Share - Security
N/A
EBITDA
-109.95M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-174.46
Shares Held By Institutions
972M
Shares Outstanding - Current
62.4M
Total Liabilities
42M
Total Volume MTD
N/A
Value
N/A
Gain YTD
12.336
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
18702 N. Creek Parkway
Phone
+1 610 321-3700
Employees
55
Web
https://www.immunome.com